Colocalization of corticotropin-releasing hormone and oestrogen receptor-α in the paraventricular nucleus of the hypothalamus in mood disorders

Brain

Volumn 128, Issue 6, 2005, Pages 1301-1313

  Bao, Ai Min ^a,b   Hestiantoro, Andon ^b   Van Someren, Eus J W ^b   Swaab, Dick F ^b   Zhou, Jiang Ning ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Corticotropin releasing hormone; Hypothalamic pituitary adrenal axis; Mood disorders; Oestrogen receptor ; Paraventricular nucleus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; THALAMUS; THALAMUS MIDLINE NUCLEUS;

AGED; BRAIN; CELL NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MOOD DISORDERS; NEURONS; ORGAN SIZE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; STAINING AND LABELING;

EID: 20444488362     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh448     Document Type: Article

References (87)

1. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992; 40: 1457-63.
2. Alves SE, Lopez V, McEwen BS, Weiland NG. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc Natl Acad Sci USA 1998; 95: 3281-6.
3. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.
4. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V. 'Serotonin depression' - a biochemical subgroup within the affective disorders? Science 1976; 191: 478-80.
5. Balthazart J, Ball GF. New insights into the regulation and function of brain estrogen synthase (aromatase). Trends Neurosci 1998; 21: 243-9.
6. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999; 84: 573-7.
7. Batschelet E. Circular statistics in biology. New York: Academic Press;, 1981.
8. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-75.
9. Bissette G. Central nervous system CRF in stress: radioimmunoassay studies. In: De Souza E, Nemeroff, CB, editors. Corticotropin-releasing factor: basic and clinical studies of a neuropeptide. Boca Raton (FL): CRC Press; 1990. p. 21-8.
10. Blaustein JD, Brown TJ, McElroy JF. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland. Neuroendocrinology 1986; 43: 143-9.
11. Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 2000: 24-9.
12. Braendgaard H, Gundersen HJ. The impact of recent stereological advances on quantitative studies of the nervous system. J Neurosci Methods 1986; 18: 39-78.
13. Cammermeyer J. Artifactual displacement of neuronal nucleoli in paraffin sections. J Hirnforsch 1967; 9: 209-24.
14. Christian JJ. Population density and reproductive efficiency. Biol Reprod 1971; 4: 248-94.
15. Chung WC, De Vries GJ, Swaab DF. Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. J Neurosci 2002; 22: 1027-33.
16. Clark AS, Nock B, Feder HH, Roy EJ. Alpha 1-noradrenergic receptor blockade decreases nuclear estrogen receptor binding in guinea pig hypothalamus and preoptic area. Brain Res 1985; 330: 197-9.
17. De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, et al. A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry 1999; 45: 1259-70.
18. De Kloet ER, Vreugdenhil, E., Oitzl, M.S., Joels, M. Glucocorticoid feedback resistance. Trends Endocrinol Metab 1997; 8: 26-33.
19. Donahue JE, Stopa EG, Chorsky RL, King JC, Schipper HM, Tobet SA, et al. Cells containing immunoreactive estrogen receptor-alpha in the human basal forebrain. Brain Res 2000; 856: 142-51.
20. Dudas B, Merchenthaler I. Close juxtapositions between LHRH immunoreactive neurons and substance P immunoreactive axons in the human diencephalon. J Clin Endocrinol Metab 2002; 87: 2946-53.
21. Erkut ZA, Hofman MA, Ravid R, Swaab DF. Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 1995; 62: 27-33.
22. Erkut ZA, Klooker T, Endert E, Huitinga I, Swaab DF. Stress of dying is not suppressed by high-dose morphine or by dementia. Neuropsychopharmacology 2004; 29: 152-7.
23. Ferin M, Vande Wiele R. Endogenous opioid peptides and the control of the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 1984; 18: 365-73.
24. Fischer P, Simanyi M, Danielczyk W. Depression in dementia of the Alzheimer type and in multi-infarct dementia. Am J Psychiatry 1990; 147: 1484-7.
25. Gambacciani M, Yen SS, Rasmussen DD. GnRH release from the mediobasal hypothalamus. In vitro regulation by oxytocin. Neuroendocrinology 1986; 42: 181-3.
26. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930-3.
27. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96: 857-81.
28. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49: 1023-39.
29. Heuser I. Depression, endocrinologically a syndrome of premature aging? Maturitas 2002; 41 Suppl 1: S19-23.
30. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 1996; 17: 187-205.
31. Hrabovszky E, Kallo I, Hajszan T, Shughrue PJ, Merchenthaler I, Liposits Z. Expression of estrogen receptor-beta messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. Endocrinology 1998; 139: 2600-4.
32. Huitinga I, van der Cammen M, Salm L, Erkut Z, van Dam A, Tilders F, et al. IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis. J Neuroimmunol 2000; 107: 8-20.
33. Ishunina TA, Swaab DF. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex. J Clin Endocrinol Metab 1999; 84: 4637-44.
34. Ishunina TA, Salehi A, Hofman MA, Swaab DF. Activity of vasopressinergic neurons of the human supraoptic nucleus is age- and sex-dependent. J Neuroendocrinol 1999; 11: 251-8.
35. Ishunina TA, Kruijver FP, Balesar R, Swaab DF. Differential expression of estrogen receptor alpha and beta immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J Clin Endocrinol Metab 2000; 85: 3283-91.
36. Jones RL. Split nucleoli as a source of error in nerve cell counts. Stain Technol 1937; 12: 91-95.
37. Koningsmark BW. Methods for counting neurons. In: Nauta WJH, Ebbesson SOE, editors. Contemporary research methods in neuroanatomy. Heidelberg: Springer; 1970.p. 315-88.
38. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol 1999; 39: 327-48.
39. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen receptor-α distribution in the human hypothalamus in relation to sex and endocrine status. J Comp Neurol 2002; 454: 115-39.
40. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen-receptor-β distribution in the human hypothalamus: similarities and differences with ER alpha distribution. J Comp Neurol 2003; 466: 251-77.
41. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM, et al. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 1998; 83: 3083-8.
42. Lehtinen V, Joukamaa M. Epidemiology of depression: prevalence, risk factors and treatment situation. Acta Psychiatr Scand Suppl 1994; 377: 7-10.
43. Levitan RD, Parikh SV, Lesage AD, Hegadoren KM, Adams M, Kennedy SH, et al. Major depression in individuals with a history of childhood physical or sexual abuse: relationship to neurovegetative features, mania and gender. Am J Psychiatry 1998; 155: 1746-52.
44. Meyer-Bahlburg HFL, Ehrhardt AA. A prenatal-hormone hypothesis for depression in adults with a history of fetal DES exposure. In: Halbreich U, editor. Hormones and depression. New York: Raven Press; 1987. p. 325-38.
45. Mitchell AJ. The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 1998; 22: 635-51.
46. Muller MB, Uhr M, Holsboer F, Keck ME. Hypothalamic-pituitary- adrenocortical system and mood disorders: highlights from mutant mice. Neuroendocrinology 2004; 79: 1-12.
47. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996; 1: 336-42.
48. Nemeroff CB. Dosing the antipsychotic medication olanzapine. J Clin Psychiatry 1997; 58 Suppl 10: 45-9.
49. Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S. Eestrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res 2002; 109: 84-94.
50. Nurnberger JI Jr, Foroud T, Flury L, Su J, Meyer ET, Hu K, et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 2001; 158: 718-24.
51. Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, Ormel J. Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res 2001; 104: 39-47.
52. Ulster DH, Ferin M. Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 1987; 65: 262-7.
53. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001; 64: 251-67.
54. Osterlund MK, Gustafsson JA, Keller E, Hurd YL. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab 2000a; 85: 3840-6.
55. Osterlund MK, Keller E, Hurd YL. The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 2000b; 95: 333-42.
56. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277: 1508-10.
57. Paykel ES. Depression in women. Br J Psychiatry Suppl 1991: 22-9.
58. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinol Metab Clin North Am 1997; 26: 279-94.
59. Petraglia F, Sutton S, Vale W, Plotsky P. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 1987; 120: 1083-8.
60. Pfaff D, Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol 1973; 151: 121-58.
61. Pryor JC, Sulser, F. Evolution of the monoamine hypothesis of depression. In: Horton R, Katona, C, editors. Biological aspects of affective disorders. New York: Academic Press; 1991. p. 77-94.
62. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996; 53: 137-43.
63. Raadsheer FC, Sluiter AA, Ravid R, Tilders FJ, Swaab DF. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 1993; 615: 50-62.
64. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436-44.
65. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372-6.
66. Reus VI, Wolkowitz OM, Frederick S. Antiglucocorticoid treatments inpsychiatry. Psychoneuroendocrinology 1997; 22 Suppl 1: S121-4.
67. Richardson RD, Boswell T, Woods SC, Wingfield JC. Intracerebroventricular corticotropin-releasing factor decreases food intake in white-crowned sparrows. Physiol Behav 2000; 71: 213-6.
68. Roselli CE, Horton LE, Resko JA. Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 1985; 117: 2471-7.
69. Sakakura M, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975; 40: 774-9.
70. Schumacher M, Balthazart J. Neuroanatomical distribution of testosterone-metabolizing enzymes in the Japanese quail. Brain Res 1987; 422: 137-48.
71. Sichel DA, Cohen LS, Robeitson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995; 38: 814-8.
72. Simonian SX, Herbison AE. Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J Neuroendocrinol 1997; 9: 803-6.
73. Steimer T, Hutchison JB. Androgen increases formation of behaviourally effective oestrogen in dove brain. Nature 1981; 292: 345-7.
74. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Over-production of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 1994; 14: 2579-84.
75. Swaab DF. The human hypothalamus. Basic and clinical aspects. Part I: nuclei of the hypothalamus. In: Aminoff MJ, Boiler F, Swaab DF, series editors. Handbook of clinical neurology. Vol. 79. Amsterdam: Elsevier; 2003. p. 476.
76. Swaab DF, Fliers E, Hoogendijk WJ, Veltman DJ, Zhou JN. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog Brain Res 2000; 126: 369-96.
77. Torpy DJ, Papanicolaou DA, Chrousos GP. Sexual dimorphism of the human stress response may be due to estradiol-mediated stimulation of hypothalamic corticotropin-releasing hormone synthesis. J Clin Endocrinol Metab 1997; 82: 982.
78. Vamvakopoulos NC, Chrousos GP. Evidence of direct oestrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92: 1896-902.
79. van de Nes JA, Kamphorst W, Ravid R, Swaab DF. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol (Berl) 1998; 96: 129-38.
80. van Praag HM. In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressions. Neuropharmacology 1983; 22: 433-40.
81. Vingerhoets AJ, Ratliff-Crain J, Jabaaij L, Tilders FJ, Moleman P, Menges LJ. Self-reported stressors, symptom complaints and psychobiological functioning-II: Psychoneuroendocrine variables. J Psychosom Res 1996; 40: 191-203.
82. Vockel A, Prove E, Balthazart J. Sex- and age-related differences in the activity of testosterone-metabolizing enzymes in microdissected nuclei of the zebra finch brain. Brain Res 1990; 511: 291-302.
83. Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, et al. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 2000; 85: 4138-45.
84. Wand G. Alcohol and the hypothalamic-pituitary-adrenal axis. Endocrinologist 1999; 9: 333-341.
85. Weiss EL, Longhurst JG, Mazure CM. Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. Am J Psychiatry 1999; 156: 816-28.
86. Young EA, Korszun A. The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin North Am 2002; 31: 63-78.
87. Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, et al. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 2001; 58: 655-62.